Search Results

There are 9052 results for: content related to: Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

  1. Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

    Cancer

    Volume 122, Issue 13, July 1, 2016, Pages: 2067–2075, Marie C. Bradley, Amanda Black, Andrew N. Freedman and Thomas I. Barron

    Version of Record online : 3 MAY 2016, DOI: 10.1002/cncr.30004

  2. Blood biomarkers for the non-invasive diagnosis of endometriosis

    Diagnostic Test Accuracy Review

    The Cochrane Library

    Vicki Nisenblat, Patrick MM Bossuyt, Rabia Shaikh, Cindy Farquhar, Vanessa Jordan, Carola S Scheffers, Ben Willem J Mol, Neil Johnson and M Louise Hull

    Published Online : 1 MAY 2016, DOI: 10.1002/14651858.CD012179

  3. You have free access to this content
    Ovarian cancer: role of ultrasound in preoperative diagnosis and population screening

    Ultrasound in Obstetrics & Gynecology

    Volume 40, Issue 3, September 2012, Pages: 245–254, Stuart Campbell

    Version of Record online : 22 AUG 2012, DOI: 10.1002/uog.12281

  4. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling

    Arthritis & Rheumatology

    Volume 67, Issue 9, September 2015, Pages: 2427–2436, Elke Theander, Roland Jonsson, Bitte Sjöström, Karl Brokstad, Peter Olsson and Gunnel Henriksson

    Version of Record online : 26 AUG 2015, DOI: 10.1002/art.39214

  5. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancer

    International Journal of Cancer

    Volume 42, Issue 5, 15 November 1988, Pages: 677–680, Vincent R. Zurawski Jr., Harald Orjaseter, Aage Andersen and Egil Jellum

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910420507

  6. CA 125 levels in patients with non-Hodgkin lymphoma and other hematologic malignancies

    Clinical & Laboratory Haematology

    Volume 27, Issue 1, February 2005, Pages: 51–55, I. DILEK, H. AYAKTA, C. DEMIR, C. MERAL and M. OZTURK

    Version of Record online : 1 FEB 2005, DOI: 10.1111/j.1365-2257.2004.00655.x

  7. Elevated serum CA-125 levels in patients with non-tuberculous mycobacterial lung disease

    Respirology

    Volume 15, Issue 2, February 2010, Pages: 357–360, Sun Young KIM, Yoonki HONG, Chang-Min CHOI, Yeon-Mok OH, Sang Do LEE, Woo Sung KIM, Dong Soon KIM and Tae Sun SHIM

    Version of Record online : 11 JAN 2010, DOI: 10.1111/j.1440-1843.2009.01686.x

  8. You have free access to this content
    The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma

    Cancer

    Volume 115, Issue 5, 1 March 2009, Pages: 1028–1035, Kristin K. Zorn, Chunqiao Tian, William P. McGuire, William J. Hoskins, Maurie Markman, Franco M. Muggia, Peter G. Rose, Robert F. Ozols, David Spriggs and Deborah K. Armstrong

    Version of Record online : 20 JAN 2009, DOI: 10.1002/cncr.24084

  9. Plasma D-dimer and peritoneal CA-125 levels as predictors of disease status in ovarian carcinoma

    Journal of Surgical Oncology

    Volume 56, Issue 3, July 1994, Pages: 168–171, Peter G. Rose, Jill M. Terrien and Stephen Baker

    Version of Record online : 19 JUL 2006, DOI: 10.1002/jso.2930560309

  10. You have free access to this content
    Serum CA 125 is of clinical value in the staging and follow-up of patients with non-hodgkin's lymphoma

    Cancer

    Volume 82, Issue 3, 1 February 1998, Pages: 576–582, Mario Lazzarino, Ester Orlandi, Catherine Klersy, Cesare Astori, Ercole Brusamolino, Alessandro Corso, Laura Bellio, Livio Gargantini, Enrica Morra and Carlo Bernasconi

    Version of Record online : 31 OCT 2000, DOI: 10.1002/(SICI)1097-0142(19980201)82:3<576::AID-CNCR21>3.0.CO;2-Y

  11. You have free access to this content
    Tumour biomarkers in heart failure: is there a role for CA-125?

    European Journal of Heart Failure

    Volume 13, Issue 6, June 2011, Pages: 579–583, Mehmet Birhan Yilmaz, Maria Nikolaou and Alain Cohen Solal

    Version of Record online : 18 FEB 2014, DOI: 10.1093/eurjhf/hfr022

  12. Quantitative and qualitative assessment of CA-125 production by human endometrial epithelial cells: Comparison of eutopic and heterotopic epithelial cells

    International Journal of Cancer

    Volume 54, Issue 3, 28 May 1993, Pages: 426–434, Hiroshi Kobayashi, Wakaba Ida, Toshihiko Terao and Yoshiro Kawashima

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910540313

  13. Prediagnostic prostate-specific antigen kinetics and the risk of biopsy progression in active surveillance patients

    International Journal of Urology

    Volume 23, Issue 4, April 2016, Pages: 313–317, Viacheslav Iremashvili, Shane L Barney, Murugesan Manoharan, Bruce R Kava, Dipen J Parekh and Sanoj Punnen

    Version of Record online : 13 JAN 2016, DOI: 10.1111/iju.13048

  14. Serum CA 125 levels during the menstrual cycle

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 97, Issue 10, October 1990, Pages: 930–933, P. LEHTOVIRTA, D. APTER and U.-H. STENMAN

    Version of Record online : 19 AUG 2005, DOI: 10.1111/j.1471-0528.1990.tb02449.x

  15. Clinical validation of the new ELSA-CA 125 II assay: Report of a european multicentre evaluation

    International Journal of Cancer

    Volume 60, Issue 2, 17 January 1995, Pages: 199–203, Maryvonne Clement, Paul Bischof, Claire Gruffat, Gabriel Ricolleau, Eliane Auvray, Véronique Quilien, Carmen Pacheco, Miguel Torres and Marco Ferdeghini

    Version of Record online : 18 JUL 2006, DOI: 10.1002/ijc.2910600212

  16. Serum CA 125 as a tumor marker and the expression of c-erbB-2 oncogene in tubal malignancies

    International Journal of Gynecological Cancer

    Volume 3, Issue 2, March/April 1993, Pages: 116–121, A.Ph. Makar, G.B. Kristensen, J. Nesland, O.P. Børmer and C.G. Tropé

    Version of Record online : 24 FEB 2002, DOI: 10.1046/j.1525-1438.1993.03020116.x

  17. The impact of CA-125 on the sensitivity of abdominal/pelvic CT scan before second-look laparotomy in advanced ovarian carcinoma

    International Journal of Gynecological Cancer

    Volume 6, Issue 3, May/June 1996, Pages: 213–218, P.G. Rose, K.L. Reuter, B.E. Nelson, J. Sirois, L. Fournier, F.R. Reale and R.E. Hunter

    Version of Record online : 24 FEB 2002, DOI: 10.1046/j.1525-1438.1996.06030213.x

  18. You have full text access to this OnlineOpen article
    Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer

    Cancer Science

    Volume 105, Issue 9, September 2014, Pages: 1205–1211, Brieze R. Keeley, Farhad Islami, Akram Pourshams, Hossein Poustchi, Jamie S. Pak, Paul Brennan, Hooman Khademi, Eric M. Genden, Christian C. Abnet, Sanford M. Dawsey, Paolo Boffetta, Reza Malekzadeh and Andrew G. Sikora

    Version of Record online : 3 SEP 2014, DOI: 10.1111/cas.12485

  19. You have free access to this content
    Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer

    International Journal of Cancer

    Volume 136, Issue 10, 15 May 2015, Pages: 2418–2426, Yin Cao, Katharina Nimptsch, Irene M. Shui, Elizabeth A. Platz, Kana Wu, Michael N. Pollak, Stacey A. Kenfield, Meir J. Stampfer and Edward L. Giovannucci

    Version of Record online : 10 NOV 2014, DOI: 10.1002/ijc.29295

  20. Preoperative CA-125 levels predict poor prognostic pathologic features in early stage, FIGO grade 1 and 2 endometrial adenocarcinoma

    International Journal of Gynecological Cancer

    Volume 3, Issue 4, July/August 1993, Pages: 259–263, P.G. Rose, F.R. Reale, M.L. Beurskens and R.E. Hunter

    Version of Record online : 24 FEB 2002, DOI: 10.1046/j.1525-1438.1993.03040259.x